The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-targeted T-cell engagement of PD1-resistant colorectal cancer cells via delivery of glycopeptide conjugates.
 
Yemi Adesokan
Employment - Gnubiotics Sciences
Leadership - Gnubiotics Sciences
Stock and Other Ownership Interests - Gnubiotics Sciences
Consulting or Advisory Role - Gnubiotics Sciences
Research Funding - Gnubiotics Sciences
Patents, Royalties, Other Intellectual Property - Gnubiotics Sciences
Travel, Accommodations, Expenses - Gnubiotics Sciences
Other Relationship - Gnubiotics Sciences
(OPTIONAL) Uncompensated Relationships - Gnubiotics Sciences
 
Marlene Schwarzfischer
No Relationships to Disclose
 
Romain Wyss
Employment - Gnubiotics Sciences
Stock and Other Ownership Interests - Gnubiotics Sciences
Research Funding - Gnubiotics Sciences
Patents, Royalties, Other Intellectual Property - Gnubiotics Sciences
 
Yong Miao
Employment - Gnubiotics Sciences
Patents, Royalties, Other Intellectual Property - Gnubiotics Sciences
 
Paul Asare
No Relationships to Disclose
 
Marianne Rebecca Spalinger
Patents, Royalties, Other Intellectual Property - Pharmabiome AG
 
Michael Scharl
Leadership - PharmaBiome; Recolony
Stock and Other Ownership Interests - PharmaBiome; Recolony
Honoraria - Bromatech; Falk Pharma; Janssen; Pileje; Vifor Pharma
Consulting or Advisory Role - Abbvie; Celltrion; Fresenius; Gilead Sciences; Roche; Takeda; Topadur
Speakers' Bureau - Bromatech; Falk Pharma; Janssen; Pileje; Vifor Pharma
Research Funding - Abbvie; Axalbion; Basilea; Calypso Medical; Gilead Sciences; Gnubiotics Sciences; Herbodee; LimmaTech Biologics; MBiomics; NodThera; Pharmabiome; Pileje; Roche; Storm Therapeutics; Takeda; Topadur; Vifor Pharma; Zealand Pharmaceuticals